Using optical markers of nondysplastic rectal epithelial cells to identify patients with ulcerative colitis-associated neoplasia

Inflammatory Bowel Diseases

Volumn 17, Issue 12, 2011, Pages 2427-2435

  Bista, Rajan K ^a   Brentnall, Teresa A ^b   Bronner, Mary P ^c   Langmead, Christopher J ^d   Brand, Randall E ^a   Liu, Yang ^a,e,f  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Carnegie Mellon University   (United States)

^e University of Pittsburgh   (United States)

^f Division of Gastroenterology Hepatology and Nutrition   (United States)

Author keywords

field effect; optical markers; spectroscopy; ulcerative colitis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON CANCER; DYSPLASIA; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; MALE; PARTIAL WAVE SPECTROSCOPIC MICROSCOPY; PRIORITY JOURNAL; RECTUM BIOPSY; RECTUM MUCOSA; SENSITIVITY AND SPECIFICITY; SPECTROSCOPY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; BAYES THEOREM; BIOPSY; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLON; COLONOSCOPY; EPITHELIAL CELLS; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; OPTICS AND PHOTONICS; PILOT PROJECTS; PRECANCEROUS CONDITIONS; RECTUM; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79958099067     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21639     Document Type: Article

References (31)

1. Hanauer SB,. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis. 2006; 12 (suppl 1): S3-S9. (Pubitemid 43068428)
2. Ekbom A, Helmik CG, Zack M, et al. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology. 1992; 103: 954-960.
3. Askling J, Dickman PW, Karlen P, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology. 2001; 120: 1356-1362. (Pubitemid 32322309)
4. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990; 323: 1228-1233. (Pubitemid 20366527)
5. Eaden JA, Abrams KR, Mayberry JF,. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001; 48: 526-535. (Pubitemid 32234798)
6. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004; 126: 451-459. (Pubitemid 38182302)
7. Chen R, Rabinovitch PS, Crispin DA, et al. DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free. Am J Pathol. 2003; 162: 665-672. (Pubitemid 36267873)
8. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983; 14: 931-968.
9. Rabinovitch PS, Dziadon S, Brentnall TA, et al. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res. 1999; 59: 5148-5153. (Pubitemid 29503975)
10. Brentnall TA, Pan S, Bronner MP, et al. Proteins that underline neoplastic progression of ulcerative colitis. Proteomics Clin Appl. 2009; 3: 1326-1337.
11. Bronner MP, O'Sullivan JN, Rabinovitch PS, et al. Genomic biomarkers to improve ulcerative colitis neoplasia surveillance. Am J Pathol. 2008; 173: 1853-1860.
12. Salk JJ, Salipante SJ, Ana Risques R, et al. Clonal expansions in ulcerative colitis identify patients with neoplasia. Proc Natl Acad Sci U S A. 2009; 106: 20871-20876.
13. Fujii S, Katsumata D, Fujimori T,. Limits of diagnosis and molecular markers for early detection of ulcerative colitis-associated colorectal neoplasia. Digestion. 2008; 77 (suppl 1): 2-12. (Pubitemid 351598542)
14. Roy HK, Kim YL, Wali RK, et al. Spectral markers in preneoplastic intestinal mucosa: an accurate predictor of tumor risk in the MIN mouse. Cancer Epidemiol Biomarkers Prev. 2005; 14: 1639-1645. (Pubitemid 40995073)
15. Subramanian H, Pradhan P, Liu Y, et al. Partial-wave microscopic spectroscopy detects subwavelength refractive index fluctuations: an application to cancer diagnosis. Opt Lett. 2009; 34: 518-520.
16. Subramanian H, Pradhan P, Liu Y, et al. Optical methodology for detecting histologically unapparent nanoscale consequences of genetic alterations in biological cells. Proc Natl Acad Sci U S A. 2008; 105: 20124-20129.
17. Subramanian H, Roy HK, Pradhan P, et al. Nanoscale cellular changes in field carcinogenesis detected by partial wave spectroscopy. Cancer Res. 2009; 69: 5357-5363.
18. Liu Y, Li X, Kim YL, Backman V,. Elastic backscattering spectroscopic microscopy. Opt Lett. 2005; 30: 2445-2447. (Pubitemid 41463515)
19. Boustany NN, Boppart SA, Backman V,. Microscopic imaging and spectroscopy with scattered light. Annu Rev Biomed Eng. 2010; 12: 285-314.
20. Kim MS, Lee J, Sidransky D,. DNA methylation markers in colorectal cancer. Cancer Metastasis Rev. 2010; 29: 181-206.
21. Shen L, Kondo Y, Rosner GL, Xiao L, et al. MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst. 2005; 97: 1330-1338. (Pubitemid 41487800)
22. 16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res. 1998; 58: 3942-3945. (Pubitemid 28405652)
23. Lashner BA, Shapiro BD, Husain A, et al. Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis. Am J Gastroenterol. 1999; 94: 456-462. (Pubitemid 29084669)
24. Holzmann K, Weis-Klemm M, Klump B, et al. Comparison of flow cytometry and histology with mutational screening for p53 and Ki-ras. mutations in surveillance of patients with long-standing ulcerative colitis. Scand J Gastroenterol. 2001; 36: 1320-1326. (Pubitemid 33027813)
25. Andersen SN, Lovig T, Clausen OP, et al. Villous, hypermucinous mucosa in long-standing ulcerative colitis shows high frequency of K-ras mutations. Gut. 1999; 45: 686-692. (Pubitemid 29492141)
26. Hsieh CJ, Klump B, Holzmann K, et al. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res. 1998; 58: 3942-3945. (Pubitemid 28405652)
27. Sato F, Harpaz N, Shibata D, et al. Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. Cancer Res. 2002; 62: 1148-1151. (Pubitemid 34160301)
28. Brentnall TA, Crispin DA, Bronner MP, et al. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res. 1996; 56: 1237-1240. (Pubitemid 26080961)
29. Issa JP, Ahuja N, Toyota M, et al. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001; 61: 3573-3577. (Pubitemid 32694963)
30. O'Sullivan JN, Bronner MP, Brentnall TA, et al. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet. 2002; 32: 280-284.
31. Watanabe T, Kobunai T, Toda E, et al. Gene expression signature and the prediction of ulcerative colitis-associated colorectal cancer by DNA microarray. Clin Cancer Res. 2007; 13: 415-420. (Pubitemid 46225344)